MedPath
NMPA Approval

Levamlodipine Besylate Tablets

国药准字H20243655

April 30, 2024

Drug Information

苯磺酸左氨氯地平片

片剂

5mg(按 C₂₀H₂₅ClN₂O₅计)

化学药品

April 30, 2024

Company Information

Applicant Company

安徽省合肥市长丰双凤经济开发区金蓉路009号

Manufacturing Company

山东省烟台市白石路102号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

苯磺酸左氨氯地平片 - NMPA 批准文号 | MedPath